首页> 外国专利> AMINO ACID SEQUENCES TARGETING HUMAN CD4, CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3- INTEGRIN, BETAL -INTEGRIN, HUMAN ALPHA2- INTEGRIN, CD81, SR-BI, CLAUDIN-I, CLAUDIN-6 AND CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY

AMINO ACID SEQUENCES TARGETING HUMAN CD4, CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3- INTEGRIN, BETAL -INTEGRIN, HUMAN ALPHA2- INTEGRIN, CD81, SR-BI, CLAUDIN-I, CLAUDIN-6 AND CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY

机译:靶向人类CD4,CXCR4,CCR5,TLR4,ALPHAV整合素,BETA3-整合素,β-整合素,人类α2-整合素,CD81,SR-BI,CLAUDIN-1,CLAUDIN-6和CLAUDIN-9的氨基酸序列。中和病毒进入

摘要

The present invention relates to amino acid sequences that are directed against (as defined herein) human cellular receptors for viruses and/or bacteria such as e.g. Nanobodies specifically recognizing hCD4, hCXCR4, hCCR5. hTLR4, human alphaV integrin, human beta3 integrin, human betal integrin, human alpha2 integrin, hCD81, hSR-Bl, hClaudin-1, hClaudin-6 and hClaudin-9, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. Said amino acid sequences may be used to prevent human cell entry of HIV, HCV, adenoviruses, hantavirus, herpesvirus, echo-virus 1 and others.
机译:本发明涉及针对(如本文所定义的)病毒和/或细菌,例如大肠杆菌的人细胞受体的氨基酸序列。特异性识别hCD4,hCXCR4,hCCR5的纳米抗体。 hTLR4,人alphaV整合素,人beta3整合素,人β整合素,人alpha2整合素,hCD81,hSR-B1,hClaudin-1,hClaudin-6和hClaudin-9,以及化合物或构建体,尤其是蛋白质和多肽,其包含一个或多个这样的氨基酸序列或基本上由其组成。所述氨基酸序列可用于防止人类细胞进入HIV,HCV,腺病毒,汉坦病毒,疱疹病毒,回声病毒1等。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号